About
Team
Portfolio
Latest
Login
RiverVest Funds I, II & III
RiverVest Fund IV
Archer Seed Fund
Latest
Select to filter latest by category
Articles
Case Studies
News & Press
Featured
News & Press
RiverVest Venture Partners Closes $275 Million Life Sciences Fund
Read More
Articles
Case Studies
Spruce Biosciences: Meeting Unmet Need with High Expertise
Articles
Portfolio Company Amplyx Pharmaceuticals Acquired by Pfizer
Featured
Case Studies
Allakos: Reining in the Immune System
Read More
Articles
What’s next for RiverVest Venture Partners after raising its largest-ever investment fund
Articles
Pascal Krotee Joins RiverVest as Senior Associate
Featured
Case Studies
InterVene: Medical Device Game-Changer in the Making
Read More
News & Press
RiverVest Expands Analyst and Marketing & Communications Teams
News & Press
RiverVest’s Tom Melzer Forecasts St. Louis VC, Start-up Growth for 2020
Previous
Next
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OK
Learn More